604
Participants
Start Date
August 21, 2012
Primary Completion Date
October 21, 2014
Study Completion Date
October 21, 2014
Lisdexamfetamine dimesylate
50 or 70 mg administered orally, once a day for 52 weeks
Klinische Forschung Dresden GmbH, Dresden
CNS Clinica, New York
Klinische Forschung Berlin-Mitte GmbH, Berlin
Bioscience Research LLC, Mount Kisco
Ernovis GmbH, Berlin
Brooklyn Medical Institute, Brooklyn
Comprehensive Clinical Development, Jamaica
Clinical Trials Research Services, LLC, Pittsburgh
Lehigh Center for Clinical Research, Allentown
The Clinical Trial Center, LLC., Jenkintown
Suburban Research Associates, Media
Neuroscience, Inc, Herndon
Charlottesville Medical Research, Charlottesville
Wake Research Associates, Raleigh
Hospital Infanta Leonor, Madrid
Coastal Carolina Research Center, Mt. Pleasant
Radiant Research, Inc, Anderson
Radiant Research, Inc, Greer
Klinische Forschung Hannover-Mitte, Hanover
Atlanta Institute of Medicine and Research, Atlanta
Neurotrials Research, Inc, Atlanta
Clinical Neuroscience Solutions, Inc, Jacksonville
Florida Clinical Research Center, LLC, Maitland
Clinical Neuroscience Solutions, Inc, Orlando
Miami Research Associates, South Miami
Scientific Clinical Research, Inc, North Miami
Fidelity Clinical Research, Inc, Lauderhill
Gulfcoast Clinical Research, Fort Myers
Florida Clinical Research, Bradenton
Compass Research, LLC, Leesburg
Birmingham Research Group, Birmingham
Clinical Research Associates, Inc, Nashville
Clinical Neuroscience Solutions, Inc (CNS Healthcare), Memphis
North Star Medical Research, LLC, Middleburg Heights
Radiant Research, Inc, Akron
Lindner Center of Hope, Mason
Patient Priority Clinical Sites, Cincinnati
Community Research, Cincinnati
Midwest Clinical Research Center, Dayton
Goldpoint Clinical Research, LLC, Indianapolis
Deaconess Health Center, Newburgh
Rochester Center for Behavioral Medicine, Rochester Hills
Dean Foundation, Middleton
University of Minnesota, Minneapolis
Capstone Clinical Research, Libertyville
American Medical Research, Inc, Oak Brook
Baber Research Group, Naperville
St. Charles Psychiatric Associates-Midwest Research Group, Saint Charles
Clinical Trials Technology, Inc, Prairie Village
Cypress Medical Research Center, LLC, Wichita
Louisana Research Associates, Inc, New Orleans
Clinical Study Centers, LLC, Little Rock
IPS Research Company, Oklahoma City
Psychiatric Medical Associates, Plano
Futuresearch Trials of Dallas, LP, Dallas
Grayline Clinical Drug Trials, Wichita Falls
Texas Center for Drug Development, Inc, Houston
Radiant Research, Inc, San Antonio
Futuresearch Clinical Trials, Austin
Western Affiliated Research Institute, Inc, Denver
Radiant Research, Inc, Denver
Radiant Research, Inc, Murray
Advanced Research Institute, Ogden
Radiant Research, Tucson
Pacific Institute for Research & Evaluation, Albuquerque
Robert Lynne Horne, MD, Las Vegas
Center for Psychiatry & Behavioral Medicine, Inc, Las Vegas
Southwestern Research, Inc., Beverly Hills
Pharmacology Research Institute, Los Alamitos
Pharmacology Research Institute, Encino
Scripps Clinical Research Services, La Jolla
Excell Research, Inc, Oceanside
PCSD - Feighner Research, San Diego
Pharmacology Research Institute, Newport Beach
TRIMED Clinical Trials, Corona
Pacific Research Partners, LLC, Oakland
Oregon Center for Clinical Research, Inc, Portland
Oregon Center for Clinical Investigations, Inc, Salem
Oregon Psychiatric Partners, Llp, Eugene
Sunstone Medical Research, LLC, Medford
Northwest Clinical Research, Bellevue
Summit Research Network (Seattle) LLC, Seattle
McLean Hospital, Belmont
Boston Clinical Trials, Boston
Activmed Practices & Research, Methuen
Adams Clinical Trials, LLC, Watertown
Global Medical Institues, LLC, Princeton
Omega Medical Research, Warwick
Neuropsychiatric Associates, Woodstock
Lead Sponsor
Shire
INDUSTRY